Smaller p-values in genomics studies using distilled auxiliary information

Medical research institutions have generated massive amounts of biological data by genetically profiling hundreds of cancer cell lines. In parallel, academic biology labs have conducted genetic screens on small numbers of cancer cell lines under custom experimental conditions. In order to share info...

Full description

Saved in:
Bibliographic Details
Published in:Biostatistics (Oxford, England) England), 2022-12, Vol.24 (1), p.193-208
Main Authors: Bryan, Jordan G, Hoff, Peter D
Format: Article
Language:English
Subjects:
Bayes Theorem
Genetic Testing
Genomics - methods
Humans
Probability
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Medical research institutions have generated massive amounts of biological data by genetically profiling hundreds of cancer cell lines. In parallel, academic biology labs have conducted genetic screens on small numbers of cancer cell lines under custom experimental conditions. In order to share information between these two approaches to scientific discovery, this article proposes a "frequentist assisted by Bayes" (FAB) procedure for hypothesis testing that allows auxiliary information from massive genomics datasets to increase the power of hypothesis tests in specialized studies. The exchange of information takes place through a novel probability model for multimodal genomics data, which distills auxiliary information pertaining to cancer cell lines and genes across a wide variety of experimental contexts. If the relevance of the auxiliary information to a given study is high, then the resulting FAB tests can be more powerful than the corresponding classical tests. If the relevance is low, then the FAB tests yield as many discoveries as the classical tests. Simulations and practical investigations demonstrate that the FAB testing procedure can increase the number of effects discovered in genomics studies while still maintaining strict control of type I error and false discovery rate.
ISSN:1465-4644
1468-4357
DOI:10.1093/biostatistics/kxaa053